Jeffrey Patton
Medical Oncology · Nashville, TNNPI 1801820519
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Karyopharm Therapeutics Inc. at 31.5% of the total.
Across 98 payments — averaging $242.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Karyopharm Therapeutics Inc.$7K
- Genentech USA, Inc.$6K
- Varian Medical Systems, Inc.$3K
- Puma Biotechnology, Inc.$3K
- Bristol Myers Squibb$1K
- Heron Therapeutics, Inc.$795
- plus $3K from 27 others
Across 2 payments — averaging $61,250 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Scientific Affairs, LLC$123K
What the payments were for
- Consulting fees$13,65557%
- Speaking & faculty fees$3,14413%
- Travel & lodging$2,77512%
- Food & beverage$4,18118%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Karyopharm Therapeutics Inc. | 4 | $7,485 |
| Genentech USA, Inc. | 6 | $5,713 |
| Varian Medical Systems, Inc. | 5 | $2,935 |
| Puma Biotechnology, Inc. | 2 | $2,623 |
| Bristol Myers Squibb | 1 | $1,144 |
| Heron Therapeutics, Inc. | 8 | $795 |
| Amgen | 11 | $734 |
| Eagle Pharmaceuticals, Inc. | 3 | $475 |
| Beigene USA, Inc. | 3 | $246 |
| Exelixis Inc. | 2 | $188 |
| Foundation Medicine, Inc. | 2 | $164 |
| Astellas Pharma US Inc | 8 | $135 |
| AstraZeneca | 4 | $125 |
| Sun Pharmaceutical Industries Inc. | 1 | $108 |
| E.r. Squibb & Sons, L.L.C. | 2 | $107 |
| Cardinal Health 108 LLC | 1 | $103 |
| Merck | 5 | $102 |
| Medtronic | 1 | $85 |
| Lilly USA, LLC | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| Bayer | 2 | $49 |
| Novartis | 3 | $46 |
| Tesaro, Inc. | 2 | $43 |
| Eisai Inc. | 2 | $34 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $33 |
| Sanofi | 2 | $31 |
| Pfizer | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Spectrum Pharmaceuticals Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPOVIO$7,485
- Radiation Oncology$2,723
- Nerlynx$2,600
- Non-Covered Product$2,052
- PEMFEXY$475
- SUSTOL$374
- CINVANTI$289
- Neulasta$268
- KANJINTI$200
- MVASI$200
- Cabometyx$145
- BRUKINSA$133
- Nplate$123
- FOUNDATIONONE$121
- FOUNDATIONONE HEME$121
- FOUNDATIONONE CDX$121
- FOUNDATIONFOCUS$121
- FOUNDATIONONE LIQUID CDX$121
How this compares
$23,775 in reported general payments places this provider in the 65th percentile of 101 medical oncology providers in Tennessee.
Other medical oncology in Nashville
- William PaoNashville$838K
- Dana ThompsonNashville$339K
- Robert RamirezNashville$321K
- Mace RothenbergNashville$318K
- Melissa JohnsonNashville$290K
- Cathy EngNashville$231K
- David SpigelNashville$167K
- Michael GibsonNashville$141K
- Jordan BerlinNashville$120K
- Vandana AbramsonNashville$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.